Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
11/27/24 Outlook Therapeutics (OTLK) Lytenava for Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
11/27/24 Applied Therapeutics (APLT) Govorestat for Metabolic - General Subscribers Only Subscribers Only Subscribers Only
11/26/24 Amgen (AMGN) MariTide for Obesity Subscribers Only Subscribers Only Subscribers Only
11/25/24 AstraZeneca (AZN) Truqap for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
11/25/24 Merck (MRK) Winrevair for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/12/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/30/2024 Subscribers Only Subscribers Only Trial Data - Updated Results
10/16/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
10/26/2024 Subscribers Only Subscribers Only Trial Data - Updated Results
10/30/2024 Subscribers Only Subscribers Only Progress Update - Development Review